Search

everythinglearnresearchcommunity

for

Search:↓

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Certain medications can cause serious side effects, so it's important to report them.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

These medications for BPH have known risks and may have new side effects.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Switching from escitalopram to duloxetine improved hair loss.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.